У нас вы можете посмотреть бесплатно Fastbase Solutions Campaign - founded by leading scientists from Cancer Research UK или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Where to invest:https://www.crowdcube.com/companies/f... Company website:http://fastbasesolutions.com/ Fastbase Solutions goal is to develop its microscopy platform, QF-Pro®, into an easy-to-use marketable healthcare product, that contributes to enhance immune-oncology treatments of cancer patients. Fastbase was founded by leading scientists from Cancer Research UK. After promising trial results,they now require funding to launch QF-Pro® commercially.We founded Fastbase with the goal of improving the lives of cancer patients. As cancer deaths exceed 10m people per year in 2020, we are developing a solution to target one of the root causes of cancer deaths: delivering proper diagnostics. Therefore, we have developed QF-Pro®, a molecular imaging technology that can map & quantify protein interactions & post-translational modifications in biopsies. These are important biological events. According to our research, their quantification by QF-Pro® can stratify patients for correct treatments, predict patient responses and survival. Our research indicates that no other product is currently offering a higher molecular resolution. Traction: ●Cooperating with renowned laboratories worldwide ●Demonstrated value in predicting patient response to immune-therapies & can predict patient survival in lung & skin cancer (published in Cancer Research) ●QF-Pro® technology is protected by patents & licenses in the main markets ●Won two international awards:the EU seal of excellence & MATWIN award in 2020. We require funding to begin our next phase: fully productising QF-Pro® & translating it to research & clinical laboratories worldwide. We believe it could improve patient outcomes of immune-oncology therapies. Our own research suggests we could expand into other diseases. The Immuno-oncology market is expected to grow at 16.5% CAGR to $37bn by 2028. https://magic.freetrade.io/join/ashik... Join me and invest commission-free with Freetrade. Get started with a free share worth £3-£200. Get free investment credit Get £25 free investment credit on seeders.com using the link:https://www.seedrs.com/signup?promo_c... Receive £25 free investment credit after successfully investing £150 or more within 30 days of signing up to Seedrs. Disclaimer: The footage in this video was created as promotional/educational material. If you are the creator or owner of the footage and have reservations please notify us via youtube comments or email and we will accommodate you. Capital at risk